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The aim of this study is to establish the effectiveness of a clinical case management (CM) programme 
compared to a standard treatment programme (STP) in patients with schizophrenia. Patients for the CM 
programme were consecutively selected among patients in the STP with schizophrenia who had poor 
functioning. Seventy-five patients were admitted to the CM programme and were matched to 75 patients 
in the STP.  Patients were evaluated at baseline and at one year follow-up. At baseline, patients in the CM 
programme showed lower levels of clinical and psychosocial functioning and more care needs than 
patients in the STP. Both treatment programmes were effective in maintaining contact with services but 
the CM programme did not show advantages over the STP on outcomes. Differences between groups at 
baseline may be masking the effects of CM at one year follow-up. A longer follow-up may be required to 
evaluate the real CM practices effects.  





Clinical case management for patients with schizophrenia with high care needs 
 
Introduction 
Case Management (CM) is one of the main components of the services for persons with severe mental 
disorders (SMDs). Although CM was initially defined as a way of coordinating resources for a patient, 
nowadays, case manager activities are broader and usually include the direct provision of services 
(Mueser, Bond, Drake, and Resnick, 1998). CM is successful in community-based models (Marshall, 
Gray, Lockwood, and Green, 2000; Mueser et al., 1998; Van Os, 2009; Ziguras and Suart, 2000) in 
outcomes such as treatment compliance, hospital admissions, satisfaction and quality of life.  
In Spain, where mental health care is community-based, CM has proven to be cost-effective in decreasing 
the burden of schizophrenia (Gutiérrez-Recacha, Chisholm, Haro Abad, Salvador-Carulla, and Ayuso-
Mateos, 2006) and use of services (Alonso Suárez et al., 2011). In Catalonia, a Spanish autonomous 
community, a new model of mental health care was developed during the transition to democracy. It led 
to a public mental health network integrated into the national health system, organised into health care 
sectors and based on Adult Mental Health Centres (AMHCs) and hospitals and community rehabilitation 
centres. AMHCs consist of multidisciplinary teams (psychiatrists, psychologists, nurses and social 
workers) that offer outpatient and specialist care for mental disorders through programmes and 
interventions included in their care services during office hours. Since their establishment, AMHCs offer 
care to patients with SMDs through a Standard Treatment Program (STP) that includes: 1) general clinical 
and psychosocial assessments; and 2) medical interventions and follow-ups. 
In 1997, the Health Department of Catalonia developed a specific type of CM programme for patients 
with SMDs that requires a higher level of care and other resources in addition to those in the STP. Its 
elements are those described by Ruggeri and Tansella (2008) and it meets the criteria of a clinical CM 
model by offering direct provision of care, and of a non-intensive CM programme since the caseload size 
is over 20 patients (Dieterich, Irving, Park, and Marshall, 2010). Table 1 shows a detailed description of 
the STP and the CM programme. All interventions in both programmes follow the Clinical Practice 
Guideline for Schizophrenia (Working group of the clinical practice guideline for schizophrenia and 
incipient psychotic disorder, 2009). 




Studies on the effects of CM in Spain are scarce, have been conducted without control groups and are 
restricted to specific outcomes (Alonso Suárez et al., 2011; Gutíerrez-Recacha et al., 2006). This paper 
deals with these issues by establishing the effectiveness of a clinical CM programme versus a STP 
regarding clinical, psychosocial and  service use variables.  
Methods 
A quasi-experimental study, pre-post, two groups, one quasi-control, was used. 
Participants 
The sample was composed of 150 patients (67.3% males; 75 in the CM programme and 75 in the STP). 
Seventy percent of patients in both programmes had illness duration longer than 10 years, 66.7% of them 
had diagnosis of paranoid schizophrenia and their mean age was 41.47 years (SD = 11.80). There were 
significant differences between the study groups in the type of housing they lived in. A lower percentage 
of patients in the CM programme reported to live in family-owned housing (See Table 2). 
Insert here Table 2 
Patients were recruited from December 2006 to January 2008 from 10 AMHCs in Barcelona (Catalonia, 
Spain). All patients had: 1) diagnosis of schizophrenia according to the International Classification of 
Diseases-10 or ICD-10 (World Health Organization [WHO], 1995), 2) illness duration greater than 2 
years and 3) clinical stability. Patients were excluded if they had dementia, organic brain injury or mental 
retardation. Patients for the CM programme were consecutively selected among those in the STP visiting 
the AMHCs with a Global Assessment of Functioning or GAF total score ≤ 50 (Endincott, 1976). Patients 
in the STP were selected from the AMHC databases through an intentional non-probabilistic sampling 
among all patients in the STP that could be matched with the patients selected for the CM programme 
regarding:  age (± 5 years), gender, illness length (± 5 years) and symptoms by the Positive and Negative 
Syndrome Scale or PANSS (Kay, Friszbein, and Opler, 1987; PANSS total score, ± 10 points) [PANSS 
total: CM=87.59, STP=85.87, t=0.851, p=0.396; PANSS positive: CM=17.60, STP=17.08, t=0.669, 
p=0.504; PANSS negative: CM=25.64, STP=25.15, t=0.537, p=0.592; PANSS general: CM=44.35, 
STP=43.64, t=0.560, p=0.576]. 
Instruments 




The Schizophrenia Cost Evaluation Questionnaire (Haro et al., 1998). It records on the use of health care 
and social services.  
The GAF (Endincott, 1976). This is a valid measure of psychological functioning in persons with SMD 
included in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (American 
Psychiatric Association [APA], 1994).  
The PANSS (Kay et al., 1987). It assesses symptom severity in persons with schizophrenia. Its validation 
into Spanish shows good psychometric properties (Peralta and Cuesta, 1994). 
The Disability Assessment Schedule short version or DAS-s (Janca et al., 1996). It is a valid and reliable 
measure of functioning for mental disorders included in the ICD-10 (WHO, 1995) validated in persons 
with schizophrenia (Mas-Expósito, Amador-Campos, Gómez-Benito, and Lalucat-Jo, 2012a). 
The Camberwell Assessment of Needs or CAN (Phelan, Slade, and Thornicroft, 1999). It measures the 
needs of people with mental illness and shows good psychometric properties in persons with 
schizophrenia (Rosales, Torres, Del Castillo, Jímenez, and Martínez, 2002). 
The World Health Organization Quality of Life Scale Brief Version (WHO, 1993) or WHOQOL-BREF. 
It is an international, cross-culturally analogous quality of life (QoL) instrument that shows good 
psychometric properties in persons with schizophrenia (Mas-Expósito, Amador-Campos, Gómez-Benito, 
and Lalucat-Jo, 2011).  
The modified DUKE-UNC Functional Social Support Questionnaire or FSSQ (Broadhead, Gelbach, 
Degruy, and Kaplan, 1988). It measures the strength of social networks. The Spanish version shows good 
psychometric properties in primary care patients (Bellón-Saameño, Delgado-Sánchez, de Dios-Luna del 
Castillo, and Lardelli-Claret, 1996) and in patients with schizophrenia (Mas-Expósito, Amador-Campos, 
Gómez-Benito, and Lalucat-Jo, 2012b). 
Procedure 
Each AMHC provided both programmes. The AMHC teams performed patient assessments. For both 
programmes, the psychiatrists established the diagnosis, following the ICD-10 (WHO, 1995) research 
diagnosis criteria and considered self and caregiver reports, and assessed psychiatric symptoms. The rest 
of assessments were performed by the other members of the teams under the psychiatrist’s supervision or 
by a community psychiatric nurse from the teams in the STP. The psychiatrist was responsible for setting 
up  and supervising the assessment agenda and sending the score sheets to the psychologist who designed 




To guarantee quality data, the psychiatrists participated in a schizophrenia diagnostic consensus workshop 
comprising two case studies. All researchers were trained in the instruments in a 4-hour session run by a 
psychologist. Systematic reviews of data coding and recording were made and patient information was 
compared with data from the AMHC responsible for each patient. 
Statistical analysis 
Clinical and psychosocial outcomes and use of health services were analysed using the Statistical Package 
for the Social Sciences v. 19. Chi-square analysis and Student’s t-tests for independent samples were used 
for categorical and continuous data, respectively. Mann–Whitney U tests were applied for continuous data 
to compare independent samples with fewer than 30 patients.  
Ethical considerations 
The study was approved by the Ethics Committee of the Catalan Union of Hospitals and carried out in 
accordance with the ethical standards of the 1964 Declaration of Helsinki. The procedures were described 
to each patient who then provided informed consent. 
Results 
A total of 69 patients (92%) in the CM programme were successfully followed up. Four individuals (out 
of 6) had no contact with services, 1 refused to participate and 1 committed suicide. Regarding the STP, 
69 patients (92%) were successfully followed up. Six patients had no contact with services. No significant 
differences between study groups were observed regarding treatment attrition (χ2(1) = 0.000; p > 0.05). 
Table 3 shows the differences between the CM programme group and the STP group in clinical and 
psychosocial variables at baseline and at one year follow-up. At baseline, no significant differences were 
found between the CM programme and the STP groups in disability, subjective QoL regarding 
psychological health, social relationships and environment, and perceived social support. However, there 
were significant differences between groups in patients’ needs from the clinician’s point of view, clinical 
and social functioning, subjective QoL regarding physical health and overall QoL (Table 3). Patients in 
the CM programme group showed more needs, lower clinical and social functioning, and lower subjective 
QoL regarding physical health and overall QoL compared to patients in the STP. At one year follow-up, 
there were intergroup differences in social functioning. Patients from the CM group showed poorer social 
functioning than patients in the STP 




Table 4 shows the use of health services for the CM group and the STP group at baseline and at one year 
follow-up for categorical variables. At baseline, there were significant differences between the study 
groups in the proportion of patients that used acute units, overall inpatient hospital services, emergency 
services and social services. A greater proportion of patients from the CM group used those services. 
After one year follow-up, there were differences between groups in the proportion of patients who used 
overall outpatient psychiatric services, community social work services, social services and primary care 
nursing services. A greater proportion of patients from the CM group used outpatient psychiatric services, 
community social work services and social services, while a greater proportion of patients from the STP 
used primary care nursing services. 
Insert here Table 4 
Table 5 shows the use of health services for the CM group and the STP group at baseline and at one year 
follow-up for continuous variables. At baseline, there were significant differences between the study 
groups in outpatient hospital visits, overall outpatient psychiatric hospital visits, community psychiatric 
visits and community psychiatric nursing visits. Patients in the CM group had more visits to all those 
services. After one year follow-up, there were differences between the groups in community psychiatric 
nursing visits. The CM programme group showed higher number of visits to community psychiatric 
nursing services. 
Insert here Table 5 
Discussion 
This paper aimed to establish the effectiveness of a CM programme versus a STP regarding clinical, 
psychosocial and service use variables.  
Both programmes were effective in maintaining contact with services. Only eight per cent of patients in 
each programme lost contact with services, which concurs with Marshall et al. (2000) with regard to the 
efficacy of CM and points out favourable effects regarding the STP. 
CM did not show any advantage over the STP on the clinical and psychosocial outcomes considered. 
Therefore, our results seem to coincide with those in a meta analyses conducted by Marshall et al. (2000) 
on the efficacy of CM versus standard care. Namely, the results of this meta analyses showed no benefit 
of CM over standard care on functioning, quality of life, needs, self-esteem, satisfaction and 




conclusions. Throughout the study, it seems there was a tendency to clinical improvement in the CM 
group, which could be masked because of baseline differences between groups. When we look at needs 
means in Table 2, we realize that, at one-year follow-up, the CM group reduced its level of needs by 
about two points while the STP group kept the same baseline level. The same trend is observed on quality 
of life concerning physical health. As for the rest of variables (i.e. clinical and social functioning and 
overall quality of life) both treatment programmes seemed to improve but those improvements seemed 
greater for the CM group. When looking at the results in this way, our findings coincide with those in a 
meta-analyses on the effectiveness of clinical CM versus usual treatment in clinical functioning (Ziguras 
and Stuart, 2000) and in other reviews (Mueser et al., 1998). Our results coincide as well with those from 
other studies (Lichtenberg, Levinson, Sharshevsky, Feldman, and Lachman, 2008) that found 
improvements in subjective QoL but with a non-validated scale. We used the WHOQOL-BREF (WHO, 
1993) which has good psychometric properties in persons with schizophrenia (Mas-Expósito et al., 
2011b). To our knowledge, this is the first study conducted in Spain dealing with this relevant outcome 
(Van Esch, Den Oudsten, and De Vries, 2011). Our results also suggest that CM was associated with 
decreasing health care needs. Studies are needed to see whether our findings are replicated. It is important 
highlighting that needs are considered a key component for the recovery of this sample population 
(Werner, 2012). A longer follow-up period might be required to determine CM effects (Lichtenberg et al., 
2008). 
CM did not show any advantage over the STP on use of health care services but, even so, it is worth to 
make some considerations since, again, baseline differences could be masking CM effects. At one year 
follow-up, most of baseline between-group differences were not present anymore. If we look in detail at 
the results of Table 4, we realize that there was a reduction by half in the proportion of patients that used 
inpatient hospital services and emergency services in the CM group. Our results seem to contradict CM 
studies in other settings where CM is associated with increasing hospitalisation (Marshall et al., 2000; 
Ziguras and Stuart, 2000). Nevertheless, they concur with Spanish studies about the effectiveness of 
clinical CM (Alonso Suárez et al., 2011) that show a drop in the number of hospitalised patients which is 
similar to that observed in our study. Alonso Suárez et al. (2011) also showed a significant decrease in the 
number of patients visiting emergency rooms. To our knowledge, ours is the second study conducted 
regarding this outcome. One should also take into account that the STP group also reduced about the 




CM group seems enough to decrease differences with the STP at one-year follow-up. Considering that 
both groups had different levels of clinical stability at baseline, we would like to suggest a longer follow-
up to evaluate CM effects at medium or long-term.  At follow-up, the CM group still used more social 
services, which may be associated to their poorer social functioning at both assessment points and there 
were new differences regarding some health care services. A higher proportion of patients in the CM 
programme group used overall outpatient hospital services, while a higher proportion of patients in the 
STP group used primary care nursing services. One possible explanation might be that, after the follow-
up, patients were ready to use less intensive services. At baseline, the CM group made more visits to 
outpatient hospital services, outpatient psychiatric hospital services, community psychiatric services and 
community psychiatric nursing services. At one year follow up, the CM programme group only showed 
more community psychiatric nursing visits. There was an increase of visits in the CM programme group 
not observed in the STP, which coincides with the metanalyses of Ziguras and Stuart (2000) that shows 
that clinical CM increases contact with services. The increase of such visits in the CM group might have 
turned into a decrease of outpatient psychiatric hospital service visits. Hospital service use was quite low, 
which contradicts the hypothesis that CM is effective where hospital bed use is high (Burns et al., 2007) 
but coincides with other Spanish studies (Alonso Suárez et al., 2011).  
Although the aforementioned strengths when comparing our study with other Spanish studies, our results 
are limited to a one year follow-up. As suggested by some authors (Björkman and Hansson, 2007), certain 
outcomes regarding CM practices for persons with SMD do not appear in a short-term perspective (i.e. 
between 6 to 24 months). In addition, we did not used a randomised controlled design but a quasi-
experimental design that is considered to be appropriate in clinical and ordinary settings, such as that in 
this study (Campbell and Stanley, 1966). Further research may consider new components in the CM 
programme such as an adjunct exercise programme, which has been considered feasible for coping with 
the high rates of morbidity and mortality in persons with schizophrenia (Sylvia et al., 2012). Other factors 
that further research may consider when evaluating CM effects is patient perceived criticism. It has been 
positively associated to higher levels of psychiatric symptoms (Guada, Hoe, Floyd, Barbour and Brekke, 
2011).  
In summary,  the CM group did not show any advantage over the STP group on clinical and psychosocial 




functioning, and more care needs than the STP group at baseline, which could be masking the results. A 
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Table 1.  Intervention Programme Characterisation  
Programme 
 ST CM 






 Community mental health nurse 
Assessment  Global assessment: 
- Medical aspects: symptoms,  clinical functioning, 
treatment adherence and drug side effects. 




- Medical assessment: symptoms, clinical functioning  treatment adherence and 
drug side effects  
- Psychosocial assessment: social functioning with special emphasis on levels of 






Development of an individualized therapeutic plan (ITP) 
- Regularly reviewed and updated (at least every three months) 
- Modified according to patients’ needs 
 
Treatment Medical intervention : 




- pharmacological treatment set up 
 
Specific psychosocial interventions:  
- Psychoeducation: educating patients and families by providing brochures and 
face-to-face sessions 




ST: Standard Treatment; CM: Case Management 
  
mobilize the social network (face-to-face and phone contacts) 
- Support in Daily Living: education on  the main aspects of personal care  
- Crisis interventions and assertive outreach: being in touch with the patient or 
family in case of an emergency situation (community face-to-face and phone 
contacts) 
 
Follow-up Medical follow-up: 4-6 visits at office per year 
 
 
Medical follow-up: 4-6 visits at office per year 
 




Table 2. Socio-demographic variables according to treatment programme  
 Programme  
 CM ST Intergroup differences 
Socio-demographic variables f (%) f (%) χ2 df p 
Male gender 51 (68.0) 50 (66.7) 0.030 1 0.862 
Diagnosis of schizophrenia type   0.348 3 0.951 
   Paranoid  50 (66.7) 50 (66.7)    
   Undifferentiated 7 (9.3) 8 (10.7)    
   Residual 10 (13.3) 8 (10.7)    
   Other 8 (10.7) 9 (12.0)    
Illness duration   0.286 2 0.867 
   < 5 years 8 (10.7) 7 (9.3)    
   From 5 to 10 years 16 (21.3) 14 (18.7)    
  > 10 years 51 (68.0) 54 (72.0)    
Marital status      
   Single 59 (78.7) 56 (74.4)   
   Married or common-law marriage 7 (9.3) 11 (14.7)   
   Separated,  divorced or widowed 9 (12.0) 8 (10.7)   
Educational level   4.678 3 0.197 
   Primary school not completed 9 (12.0) 7 (9.3)   
   Primary school 26 (34.7) 35 (46.7)   
   Secondary school 31 (41.3) 20 (26.7)   
   College or university 9 (12.0) 13 (17.3)   
Living situation   5.864 5 0.320 




   With son/daughter or son/daughter and partner 5 (6.7) 7 (9.3)   
   With partner 5 (6.7) 9 (12.0)   
   With parents 35 (46.7) 39 (52.0)   
   With other relatives 6 (8.0) 6 (8.0)   
   With other people or in an institution  8 (10.7) 2 (2.7)   
Type of housing   9.832 2 0.007     
   Family-owned 43 (57.3) 60 (80.0)   
   Rented 21 (28.0) 12 (16.0)   
   Hostel, supported sheltered  house,  therapeutic community, homeless or others 11 (14.7) 3 (4.0)   
Employment status   2.331 3 0.507 
   Employed/self-employed/ supported employment/student/volunteer 7 (9.3) 13 (17.3)   
   House work/on sick leave/retired/unemployed 14 (18.7) 12 (16.0)   
   Never worked before 7 (9.3) 5 (6.7)   
   Incapacitated 47 (62.7) 45 (60.0)   
 Mean (SD)   Mean (SD) t    
Age 41.23 (11.98) 41.72 (11.70) –0.255 148 0.799 
 
Note. n=75 for the case management and the standard treatment programmes 





Table 3. Clinical and psychosocial variables in the case management programme group and the standard treatment programme group at baseline and at one year 
follow-up 
 
   Programmes  
Measure Time (months) CM ST Intergroup differences 
  Mean (SD) Mean (SD) t p 
CAN patients’ needs  0 9.14 (7.43) 7.43 (3.32) 2.784 0.006 
 12 7.89 (3.56) 7.01 (2.80) 1.527 0.129 
GAF clinical  0 42.03 (7.15) 47.01 (8.71) –3.834 < 0.001 
 12 46.65 (11.20) 49.14 (10.46) –1.351 0.179 
GAF social  0 40.44 (8.63) 45.27 (9.10) –3.335 0.001 
 12 42.35 (9.43) 47.04 (10.77) –2.725 0.007 
DAS-s 0 10.20 (4.51) 9.03 (3.86) 1.712 0.089 
 12 9.03 (4.46) 8.93 (4.36) 0.135 0.893 
WHOQOL-BREF physical health 0 12.64 (2.25) 13.61 (2.29) –2.614 0.010 
 12 13.00 (2.64) 13.62 (2.20) –1.499 0.136 
WHOQOL-BREF psychological health 0 11.64 (2.80) 12.36 (2.57) –1.621 0.107 
 12 12.02 (2.82) 12.46 (2.56) –0.969 0.334 
WHOQOL-BREF social relationships 0 10.17 (3.20) 10.52 (2.90) –0.713 0.477 
 12 12.30 (3.18) 10.43 (2.95) –0.259 0.796 
WHOQOL-BREF environment 0 12.75 (2.28) 13.16 (2.04) –1.156 0.250 
 12 13.07 (2.27) 13.63 (2.43) –1.412 0.160 
WHOQOL-BREF general 0 78.12 (13.14) 82.72 (11.82) –2.254 0.026 
 12 80.51 (14.46) 83.72 (12.23) –1.411 0.161 




 12 37.22 (10.02) 36.64 (8.71) 0.363 0.717 
FSSQ confidant support 0 16.40 (5.20) 16.97 (4.80) –0.699 0.486 
 12 16.72 (4.96) 16.51 (5.19) 0.252 0.802 
FSSQ affective support 0 10.82 (3.20) 11.16 (3.08) –0.652 0.516 
 12 11.16 (3.18) 10.75 (3.11) 0.757 0.450 
Note. n=75 at baseline and n=69 at one year follow-up for the case management and standard treatment programmes 
CM: Case Management; ST: Standard Treatment; SD: Standard Deviation; CAN: Camberwell Assessment of Needs Questionnaire; PANSS: Positive and Negative 
Syndrome Scale; GAF: Global Assessment of Functioning; DAS-s: Disability Assessment Schedule Short Form; WHOQOL-BREF: World Health Organization 





Table 4. Use of services (categorical variables) according to treatment programme 
  CM ST    
 Time 
(months) 
f % f % χ2 df p 
Inpatient hospital services         
Acute unit 0 20 26.7 10 13.3 4.167 1 0.041 
 12 10 14.5 4 5.8 2.862 1 0.091 
Sub-acute unit 0 5 6.7 3 4.0 0.528 1 0.467 
 12 4 5.8 1 1.4 1.868 1 0.172 
General hospital unit 0 2 2.7 0 0 2.027 1 0.155 
 12 0 0 0 0 - - - 
Overall use of inpatient hospital services 0 24 32.0 12 16.0 5.263 1 0.022 
 12 11 15.9 6 8.7 1.677 1 0.195 
Outpatient hospital services         
Day hospital 0 4 5.3 2 2.7 0.174* 1 0.677 
 12 0 0 1 1.4 1.007* 1 1.000 
Outpatient hospital services 0 5 6.7 5 6.7 0.000 1 1.000 
 12 2 2.9 0 0 0.507** 1 0.154 
Emergency services 0 17 22.7 8 10.7 3.888 1 0.049 
 12 9 13.0 3 4.3 3.286 1 0.070 
Crisis services 0 3 4.0 1 1.3 1.027** 1 0.620 
 12 1 1.4 0 0 1.007 1 1.000 
Overall use of outpatient hospital services 0 22 29.3 15 20.0 1.758 1 0.185 
 12 12 17.4 3 4.3 6.059 1 0.014 




Note. *Yate’s test continuity correction; **Excat Fisher Test 
CM: Case Management; ST: Standard Treatment; f: frequency; %: percentage; df: degrees of freedom 
 
Community psychological services 0 10 13.3 10 13.3 0.000 1 1.000 
 12 6 8.7 6 8.7 0.000 1 1.000 
Community social work services 0 42 56 33 44.0 2.160 1 0.142 
 12 52 69.3 38 50.7 5.444 1 0.020 
Community rehabilitation services 0 16 21.3 13 17.3 0.385 1 0.535 
 12 19 27.5 12 17.4 2.039 1 0.153 
Specialised rehabilitation services 0 14 18.7 8 10.7 1.918 1 0.166 
 12 16 23.2 9 13.0 2.394 1 0.122 
Protected vocational workshops 0 6 8.0 6 8.0 0.000 1 1.000 
 12 3 4.3 6 8.7 1.070 1 0.301 
Educational, vocational or leisure services 0 11 14.7 18 24.0 2.095 1 0.148 
 12 10 14.5 15 21.7 1.221 1 0.269 
Social services 0 16 21.3 1 1.3 14.927 1 0.000 
 12 9 13.0 2 2.9 4.840 1 0.028 
Emergency phone calls 0 9 12.0 6 8.0 0.667 1 0.414 
 12 4 5.8 5 7.2 0.119 1 0.730 
Primary care services         
General practitioner 0 47 62.7 47 62.7 0.000 1 1.000 
 12 49 71.0 52 75.4 0.332 1 0.564 
Primary care nursing 0 19 25.3 25 33.3 1.158 1 0.282 
 12 17 24.6 28 40.60 3.990 1 0.046 
Home, family and social work 0 9 12.0 3 4.0 3.261 1 0.071 




Table 5. Service use variables in the case management programme group and the standard treatment programme group at baseline and at one year follow-up 
 
  Programme  
Service Time 
(months) 
CM  ST Intergroup differences 
  n Mean (SD) n Mean (SD) T /Z p 
Inpatient  hospital services        
Acute psychiatric unit (days) 0 20 17.84 (11.41) 10 22.56 (9.28) –1.480 0.139 
 12 10 18.13 (8.54) 4 15.75 (10.81) –0.681 0.496 
Acute psychiatric unit (admissions) 0 20 1.00 (0.00) 10 1.00 (0.00) - - 
 12 10 1.00 (0.00) 4 1.25 (0.50) –1.414 0.157 
Crisis unit (days) 0 0 0.00 (0.00) 0 0.00 (0.00) - - 
 12 1 18.00 (0.00) 0 0.00 (0.00) - - 
Crisis unit (admissions) 0 0 0.00 (0.00) 0 0.00 (0.00) - - 
 12 1 1.00 (0.00) 0 0.00 (0.00) - - 
Sub-acute unit (days) 0 5 62.40 (38.19) 3 88.00 (67.62) –1.050 0.294 
 12 4 67 (27.40) 1 29.50 (9.19) –1.732 0.083 
Sub-acute unit (admissions) 0 5 1.00 (0.00) 3 1.00 (0.00) - - 
 12 3 1.00 (0.00) 2 1.00 (0.00) - - 
Medium/long stay unit (days) 0 0 0.00 (0.00) 0 0.00 (0.00) - - 
 12 0 0.00 (0.00) 1 6.00 (0.00) - - 
Medium/long stay unit (admissions) 0 0 0.00 (0.00) 0 0.00 (0.00) - - 
 12 0 0.00 (0.00) 0 0.00 (0.00) - - 
General hospitalisation unit (days) 0 2 2.00 (1.41) 0 0 - - 




General hospitalisation unit (admissions) 0 2 1.00 (0.00) 0 0 - - 
 12 0 0.00 (0.00) 0 0.00 (0.00) - - 
Overall inpatient hospital (days) 0 24 29.68 (29.86) 12 21.30 (9.60) –0.293 0.770 
 12 11 46.18 (51.20) 6 21.33 (19.49) –1.409 0.159 
Overall inpatient hospital (admissions) 0 24 1.00 (0.00) 12 1.00 (0.00) - - 
 12 11 1.45 (0.69) 6 1.00 (0.00) –1.348 0.178 
Outpatient psychiatric hospital services        
Outpatient hospital visits  0 5 17.80 (13.18) 5 1.25 (0.50) –2.491 0.013 
 12 2 3.00 (2.83) 0 0 - - 
Crisis unit visits  0 3 1.00 (0.00) 1 4.00 (0) –1.732 0.083 
 12 1 1.00 (0.00) 0 0 - - 
Emergency service visits 0 17 1.53 (0.74) 8 1.38 (0.74) –0.612 0.540 
 12 9 2.11 (1.69) 3 16.67 (24.58) –1.025 0.413 
Day hospital 0 4 55.00 (54.08) 2 160.00 (224.86) –0.651 0.628 
 12 0 0.00 (0.00) 1 9.00 (0.00) - - 
Outpatient psychiatric hospital visits 0 20 8.40 (11.24) 13 1.62 (0.96) 2.684 0.039 
 12 12 2.17 (1.75) 3 19.67 (29.77) –1.023 0.306 
Community services        
Community psychiatric visits 0 73 5.85 (2.94) 73 4.70 (2.54) 2.528 0.013 
 12 68 6.18 (3.50) 69 5.22 (2.57) 1.830 0.069 
Community psychology visits 0 10 4.22 (2.86) 10 5.90 (4.41) –0.495 0.621 
 12 6 6.50 (4.51) 6 4.67 (2.94) –1.158 0.247 
Community psychiatric nursing visits 0 75 7.81 (7.48) 74 4.42 (5.38) 3.183 0.002 
 12 69 11.64 (8.35) 68 4.94 (5.97) 5.409 0.000 
Community social work visits 0 42 4.55 (3.59) 33 4.79 (3.57) –0.288 0.774 




Community rehabilitation centre 0 16 183.63 (168.19) 13 252.62 (138.13) –0.774 0.439 
 12 19 132.32 (168.99) 12 242.92 (140.52) –1.453 0.146 
CM: Case Management; ST: Standard Treatment; SD: Standard Deviation 
 
 
 
 
